StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SRHHYPOLTD.NS$510.95+1.11%
Fair $510.95+0.0%

SRHHYPOLTD.NS

Sree Rayalaseema Hi-Strength Hypo Limited

Basic Materials / ChemicalsNSE

$510.95

+5.60 (+1.11%)

Fairly Valued+0.0%Fair Value $510.95Fund rank 35/100 · Data gapFallback financials|
SA 44/C
F-Score: 4/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.2B · quality 72.3/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 63/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 2 consecutive years
Thesis & Journal · SRHHYPOLTD.NSLocal privado en este navegador · Sree Rayalaseema Hi-Strength Hypo Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.8B

P/E

9.4x

↓

EV/EBITDA

4.1x

↓

ROE

9.8%

↑

Gross Margin

44.2%

↑

Debt/Equity

0.02

↓
52-Week Range$511
$382$717

TradingView lightweight chart

SRHHYPOLTD.NS price, volumen y niveles de valoración

Último $510.95Periodo +2046.8%
Fair value: $510.95

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-20.5%

FCF CAGR

+11.6%

FCF margin

9.9%

FCF / Net income

0.70x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.35B · net income $900.7M · FCF $630.5M

2022-FY → 2025-FY

Gross margin

44.2%+17.6% pts

Operating margin

13.6%+3.4% pts

Net margin

14.2%+6.1% pts

FCF margin

9.9%+6.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$6.35B$6.35B$8.62B$16.45B$12.63B
Net Income$900.7M$900.7M$790.6M$1.54B$1.03B
EBITDA$1.28B$1.28B$1.19B$2.13B$1.58B
EPS52.4752.4746.0689.8759.88
Gross Margin44.2%44.2%34.4%24.4%26.6%
Operating Margin13.6%13.6%11.8%9.8%10.3%
Net Margin14.2%14.2%9.2%9.4%8.1%
Balance Sheet
Debt/Equity0.020.020.020.030.05
Cash Flow
Free Cash Flow$630.5M$630.5M$1.20B$1.33B$453.5M
Returns
ROE9.8%9.8%9.9%20.5%18.0%
Valuation
P/E9.399.3912.515.187.61
EV/EBITDA4.104.105.642.785.03
P/B0.960.961.241.061.37
Growth & Yield
Revenue Growth-26.3%-26.3%-47.6%30.3%—
EPS Growth13.9%13.9%-48.7%50.1%—
Dividend Yield0.5%0.5%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-4.8%

fácil

EPS terminal req.

$45.34

Spread vs growth

18.7%

5Y implied EPS CAGR

0.9%

fácil

EPS terminal req.

$54.86

Spread vs growth

13.0%

10Y implied EPS CAGR

5.3%

razonable

EPS terminal req.

$88.35

Spread vs growth

8.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -10.8%

Total return

-10.8%

Start / end P/E

12.5x → 9.7x

EPS bridge

46.06 → 52.47

Residual

-3.1%

EPS growth+13.9%
Multiple rerating-22.2%
Dividend+0.5%
Residual / FX / buybacks / cross-term-3.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.